Prostatic hyperplasia : Evaluation of practices in general practice, dissemination, and impact of recommendations
Copyright © 2022 Elsevier Masson SAS. All rights reserved..
INTRODUCTION: In 2015, the French Association of Urology, by the male lower urinary tract symptoms Committee, published a practices guideline for the management of prostatic hyperplasia in general practice. Five years after the publication of these recommendation, our objective is to assess their dissemination and their impact in general practice.
MATERIAL: A specially designed questionnaire was distributed online via the departmental councils of the order and to all regional unions of liberal doctors. The distribution to general practitioners was at the discretion of each organisation depending on local policies.
RESULTS: Two hundred and eighty responses were collected. Fifty-five percent of the population was female. 83 % of the general practitioners did not report having knowledge of the practice guideline. 77 % of doctors stated that they had not received training or information on prostatic hyperplasia in the past 5 years. Among the notable results, 51 % of general practitioners declared performing a digital rectal examination. 44 % prescribed an endorectal ultrasound. Only 7 % of doctors were aware of the existence of minimally invasive surgical techniques.
CONCLUSION: The practices guideline for the management of prostatic hyperplasia in general practice proposed in 2015 by the male lower urinary tract symptoms Committee seems to be little known by general practitioners. Dissemination of these recommendations solely through publication in Progrès en Urologie seems ill-suited to consideration by general practitioners, and it seems necessary to consider other modes of dissemination.
LEVEL OF EVIDENCE: 4, grade C.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 33(2023), 2 vom: 13. Feb., Seite 58-65 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
L’hypertrophie bénigne de prostate : évaluation des pratiques en médecine générale, diffusion et impact des recommandations |
|---|
| Beteiligte Personen: |
Mesnard, B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
English Abstract |
|---|
| Anmerkungen: |
Date Completed 31.01.2023 Date Revised 02.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.purol.2022.06.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343625709 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343625709 | ||
| 003 | DE-627 | ||
| 005 | 20231226020903.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.purol.2022.06.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343625709 | ||
| 035 | |a (NLM)35842333 | ||
| 035 | |a (PII)S1166-7087(22)00163-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Mesnard, B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prostatic hyperplasia |b Evaluation of practices in general practice, dissemination, and impact of recommendations |
| 246 | 3 | 3 | |a L’hypertrophie bénigne de prostate : évaluation des pratiques en médecine générale, diffusion et impact des recommandations |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2023 | ||
| 500 | |a Date Revised 02.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a INTRODUCTION: In 2015, the French Association of Urology, by the male lower urinary tract symptoms Committee, published a practices guideline for the management of prostatic hyperplasia in general practice. Five years after the publication of these recommendation, our objective is to assess their dissemination and their impact in general practice | ||
| 520 | |a MATERIAL: A specially designed questionnaire was distributed online via the departmental councils of the order and to all regional unions of liberal doctors. The distribution to general practitioners was at the discretion of each organisation depending on local policies | ||
| 520 | |a RESULTS: Two hundred and eighty responses were collected. Fifty-five percent of the population was female. 83 % of the general practitioners did not report having knowledge of the practice guideline. 77 % of doctors stated that they had not received training or information on prostatic hyperplasia in the past 5 years. Among the notable results, 51 % of general practitioners declared performing a digital rectal examination. 44 % prescribed an endorectal ultrasound. Only 7 % of doctors were aware of the existence of minimally invasive surgical techniques | ||
| 520 | |a CONCLUSION: The practices guideline for the management of prostatic hyperplasia in general practice proposed in 2015 by the male lower urinary tract symptoms Committee seems to be little known by general practitioners. Dissemination of these recommendations solely through publication in Progrès en Urologie seems ill-suited to consideration by general practitioners, and it seems necessary to consider other modes of dissemination | ||
| 520 | |a LEVEL OF EVIDENCE: 4, grade C | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a General practice | |
| 650 | 4 | |a Hypertrophie bénigne de prostate | |
| 650 | 4 | |a Médecine générale | |
| 650 | 4 | |a Practices guidelines as topic | |
| 650 | 4 | |a Prostatic hyperplasia | |
| 650 | 4 | |a Recommandations de pratiques professionnelles | |
| 700 | 1 | |a Lecoq, J |e verfasserin |4 aut | |
| 700 | 1 | |a De Vergie, S |e verfasserin |4 aut | |
| 700 | 1 | |a Perrouin Verbe, M A |e verfasserin |4 aut | |
| 700 | 1 | |a Chelghaf, I |e verfasserin |4 aut | |
| 700 | 1 | |a Karam, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rigaud, J |e verfasserin |4 aut | |
| 700 | 1 | |a Descazeaud, A |e verfasserin |4 aut | |
| 700 | 1 | |a Robert, G |e verfasserin |4 aut | |
| 700 | 1 | |a Branchereau, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie |d 1997 |g 33(2023), 2 vom: 13. Feb., Seite 58-65 |w (DE-627)NLM012649481 |x 1166-7087 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2023 |g number:2 |g day:13 |g month:02 |g pages:58-65 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.purol.2022.06.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2023 |e 2 |b 13 |c 02 |h 58-65 | ||